Replies to post #563057 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Automated manufacturing of dcvax is the long pole in the tent and that would have been true at CRL as well. The Sawston facility approval process seems to be moving along as expected.

Of course Automated manufacturing of dcvax is the long pole in the tent, What Powers should have done is get approval first based on manual production in cooperation with CRL in the US first, right after data lock with the FDA. In that case, DCVAXL L would have gotten approval 6 months ago already. Stock goes to $10. Then sell 50 million shares. With that cash, NWBO could have started or bought a CDMO for automated DCVAXL production and after that cancel the contract with CRL. Its not complicated.